Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

They join an esteemed group of IPC psoriasis experts working to better patient care

We are pleased to introduce our newest IPC Councilors, including for the first time, dermatologists from Bangladesh and Guatemala. Councilors are selected based on overall reputation in the dermatology community, involvement in psoriasis research, and demonstrated interest in psoriasis care and treatment.  

Meet our councilors

Charlotte Enerbäck, MD, PhD
Linköping University
Linköping, Sweden

Charlotte Enerbäck, MD, PhD, is Professor of Dermatology at Linköping University since 2013 and serves as the chair of the Department of Dermatology in Linköping.

Prof. Enerbäck is responsible for the undergraduate dermatology curriculum at Linköping University and is member of the board of the Faculty of Medicine at Linköping University. She serves as a senior consultant at the Department of Dermatology at Linköping University hospital where she is the head of the psoriasis specialist outpatient clinic.

Prof. Enerbäck received her medical degree and a PhD in psoriasis genetics from the Gothenburg University Medical School where she also completed her residency. She is board certified in Dermatology and Clinical Genetics. Prof. Enerbäck completed a post-doc at Dana Farber Cancer Institute, Harvard Medical School, and a sabbatical at the Department of Dermatology, University of Michigan Medical School. She belongs to several advisory boards in psoriasis and is a member of the European Dermatology Forum.

Last Updated: Sep 22, 2020

Joseph Merola, MD, MMSc
Harvard Medical School
Boston, Massachusetts, United States

Joseph F. Merola, MD, MMSc, is Associate Professor in the Department of Dermatology and Department of Medicine, Division of Rheumatology at Harvard Medical School in Boston, Massachusetts.

Dr. Merola is board-certified in Dermatology, Internal Medicine, and Rheumatology.  He serves as the Vice Chair for Clinical Trials, the Director of the Clinical Unit for Research Innovation and Trials (CUReIT), Director of the Center for Skin and Related Musculoskeletal Diseases and the Associate Program Director for the Harvard Combined Internal Medicine-Dermatology Residency Training Program at Brigham and Women’s Hospital in Boston. He is an associate physician in the Department of Pharmaco-epidemiology and Pharmaco-economics at Brigham and Women’s Hospital where he co-directs a Dermato-Pharmaco-epidemiology program and fellowship. 

Dr. Merola earned his medical degree at New York University School of Medicine in New York, New York, followed by his Master of Medical Sciences degree at Harvard Medical School. He completed an internship in Internal Medicine at the Hospital of the University of Pennsylvania in Philadelphia, followed by a residency in Dermatology at New York University Medical Center. He continued with a residency in Internal Medicine and a fellowship in Rheumatology at Brigham and Women’s Hospital.

Dr. Merola is on the Medical Board of the National Psoriasis Foundation, the Board of the International Dermatology Outcome Measures Group and Executive Committee for GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis), the Board of the Lupus Foundation of America and is on the Board and Founding President of the Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN).  President-elect of the Medical Dermatology Society.

Last Updated: Sep 14, 2020

Mohammad Rafiqul Mowla, MBBS, MD
Chittagong Medical College
Chittagong, Bangladesh

Mohammad Rafiqul Mowla, MBBS, MD is a Clinical Professor in Dermatology and Venereology and has a long-standing practice in institutional clinical setting.

Dr. Mowla serves as Associate Professor in the Department of Dermatology and Venereology at Chittagong Medical College, Bangladesh, where he directs the department's research department and mentors post-doc, graduate and undergraduate students. Currently, he is heading efforts in his department to initiate clinical trials in patients with autoimmune and inflammatory skin diseases to test drugs that were developed largely based on preclinical and translational research.

Dr. Mowla received the Global Education Award from the International Society of Dermatology, the Strauss & Katz Award from the American Academy of Dermatology, and the World Congress of Dermatology 2015 and 2019 Scholarship Award from the International League of Dermatological Societies.

He is an author of many publications in national and international scientific journals, original articles, clinical and scientific research studies, epidemiological reports and abstracts presented at national and international congresses. He has co-authored many scientific publications in reputed peer reviewed journals (JAAD, JEADV, IJD, CDJ, STI, CED, SHD, Dermatologic Therapy, Forum Dermatologicum, GJDV, JCMTA and BJDVL etc.) and has been serving as an editorial board member in three national and international journals.

Dr. Mowla is passionate about the Internet and its use for diagnostic teledermatology, medical education, and consumer health information. He is excited about the promise of artificial intelligence in widening access to dermatological expertise. 

Last Updated: Sep 14, 2020

Stefano Piaserico, MD, PhD
University of Padua, Italy
Padua, Italy

Stefano Piaserico, MD, PhD is an Assistant Professor at the University of Padua, Italy and head of the Regional Centre for Psoriasis.  Prof. Piaserico qualified in Medicine and Surgery in 1997 from the University of Padua and was awarded a PhD in Biochemistry and Biophysics. His thesis focused on photodynamic therapy in dermatology.

Prof. Piaserico conducted research at the Regional Centre for Melanoma at Istituto Oncologico Veneto in Italy. His research is based in dermatology and venereology with a key focus on psoriasis, psoriatic arthritis, organ transplant recipients, photodynamic therapy and skin cancer. Prof. Piaserico has built up a wide portfolio of more than 140 publications in several scientific journals and is an associate of numerous professional organizations including the Italian Society of Dermatology and the European Academy of Dermatology and Venereology. 

Last Updated: Sep 14, 2020

Enrique Rivas, MD
DERMOS Research Center
Guatemala City, Guatemala

Enrique Rivas, MD is a pediatric dermatologist in Guatemala. Dr. Rivas is a medical investigative director for DERMOS research center, working in monoclonal antibodies psoriasis therapy trials, where he also maintains a private practice. Certified as medical and surgical dermatologist at the Instituto de Dermatología y Cirugía de Piel de Guatemala – INDERMA and pediatric dermatologist at Instituto Nacional de Pediatría - INP in Mexico.

Dr. Rivas was an adjunct professor of pediatric dermatology and clinical immunology and teaching and research coordinator at INDERMA (2009-2011). He has authored numerous papers and made several national and international presentations on psoriasis. He is the Global Psoriasis Atlas representative for Guatemala. 

Last Updated: Sep 17, 2020

Stay informed

Join the email list to receive the latest information on psoriasis meetings, manuscripts and research.

now available

COVID-19 Psoriasis Resource Center

Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve

explore now


on SARS-CoV-2 Vaccines and Psoriasis

Six key take-aways that physicians and other healthcare practitioners should consider when administering the SARS-CoV-2 vaccine to psoriasis patients.


We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.